Skip to main content

Mid-Year Meeting 2023 Main banner

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D
Damase-Michel, Christine

Université Toulouse III
OP1-4 - Distinguishing between indications for use of medications in administrative data sources Application to pregabalin and gabapentin A contribution from the ConcePTION project
Location: Room A
Christine Damase-Michel
Dave, Chintan

Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
OP3-2 - Disparities in the uptake of newer anticoagulant therapies for atrial fibrillation by race, ethnicity and social vulnerability in Medicare fee-for-service data
Location: Room a
Chintan Dave
De Bruin, Marie Louise

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
OP2-0 - Student Oral Presentations Session II
Location: Room A
Marie Louise De Bruin
OP4-3 - Description of the delay in completion of studies that evaluate the effectiveness of additional risk minimization measures
Location: Room A
Marie Louise De Bruin
de Groot, Jolien

Dutch Medicines Evaluation Board
OP4-1 - Feasibility of post-authorization randomized controlled trials for conditionally authorized anticancer medicines - a multistakeholder perspective
Location: Room A
Jolien de Groot
Delmestri, Antonella

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
OP4-5 - Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications
Location: Room A
Antonella Delmestri
OP4-6 - Common comorbidities and COVID-19 mortality: an empirical comparison of primary care alone vs additional hospital data linkage for association analyses
Location: Room A
Antonella Delmestri